A Study to Find RNA Markers that Describe the Underlying Inflammatory Process and Can Help Direct Therapy

Overview

About this study

The purpose of the study is to find specific and sensitive RNA markers that not only describe the underlying inflammatory process, but can help direct therapy by identifying the likely causative pathogen in cases of infection.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  1. Patients aged 18 or older
  2. Patients able to give consent (or their legal representative)
  3. Paitents amendable to safe obtain CSF sampling safely via an existing ventricular drains (EVD) placed by standard of care (SOC), or via SOC LP (no supratentorial lesion causing increased intracranial pressure)
  4. No localized infection at the site of needle insertion
  5. Hemodynamically stable to lay flat for the procedure

Exclusion Criteria

  1. Vulnerable populations (prisoners, pregnant women)
  2. Inability to provide consent

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Jacksonville, Fla.

Mayo Clinic principal investigator

John Fryer, Ph.D.

Closed for enrollment

More information

Publications

Publications are currently not available

Additional contact information

Non-cancer trials contact form

Phone: 800-664-4542 (toll-free)

International patient clinical studies questions